文献速递心脑血管急症

T2 mapping评估ST段抬高型心肌梗死患者心肌改变及预后意义

[Prognostic significance of T2 mapping in evaluating myocardium alterations in patients with ST segment elevation myocardial infarction].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论急性STEMI患者native-T1与T2值显著升高,T2 cut-off 46.7 ms鉴别急性期与慢性期特异性100%、敏感性73.8%。

回顾性研究纳入30例急性STEMI患者(实验组)与30例年龄性别匹配的健康志愿者及非特异性胸痛且CMR无异常的门诊患者(对照组),于诊断STEMI后2周内行CMR作为初始参考,6个月后复查平扫CMR(慢性心肌梗死,CMI)。实验组native-T1值、T2值、ECV均显著高于对照组。6个月后12例复查者T2-STIR高信号仍可见但范围较急性期缩小,native-T1与T2值显著低于急性期。ROC分析native-T1与T2值鉴别急性STEMI与CMI的AUC分别为0.71和0.80;native-T1 cut-off 1 316.0 ms时特异性100%、敏感性53.3%,T2 cut-off 46.7 ms时特异性100%、敏感性73.8%。作者认为T2 mapping是无创诊断急性STEMI心肌改变并可用于评估临床预后的方法。

要点

  • 急性STEMI患者T2值(ms)48.3±15.6 vs 对照组21.8±13.1,native-T1值(ms)1 434.5±165.3 vs 1 237.0±102.5,ECV(%)39.6±13.8 vs 22.8±5.0,均P < 0.05。
  • 6个月后12例复查者T2值(ms)34.2±11.2 vs 急性期48.3±15.6,native-T1值(ms)1 271.0±26.9 vs 1 434.5±165.3,均P < 0.05。
  • T2值鉴别急性STEMI与CMI的AUC为0.80,cut-off 46.7 ms时特异性100%、敏感性73.8%。
  • native-T1值鉴别急性STEMI与CMI的AUC为0.71,cut-off 1 316.0 ms时特异性100%、敏感性53.3%。
  • 6个月后T2-STIR高信号仍可见但范围较急性期缩小。

适用人群与场景

  • 2021年1月至2022年3月天津市第一中心医院收治的30例急性STEMI患者作为实验组。
  • 同期选择30例年龄、性别匹配的健康志愿者及心脏磁共振(CMR)检查无异常的非特异性胸痛门诊患者作为对照组。

诊断标准与关键阈值

  • 于诊断STEMI后2周内行CMR作为初始参考,6个月后行平扫CMR复查(慢性心肌梗死,CMI)。
  • 平扫序列包括电影序列(CINE)、T2加权短tau反转恢复(T2-STIR)、native-T1 mapping和T2 mapping;增强扫描包括首过灌注、晚期钆增强(LGE)和增强后T1 mapping。

研究设计与关键结果

  • 回顾性研究,实验组30例急性STEMI患者,对照组30例年龄性别匹配的健康志愿者及CMR无异常的非特异性胸痛门诊患者;两组年龄、性别、心率、体重指数(BMI)差异无统计学意义,具有可比性。
  • 实验组native-T1值、T2值、ECV均显著高于对照组:native-T1值(ms)1 434.5±165.3 vs 1 237.0±102.5,T2值(ms)48.3±15.6 vs 21.8±13.1,ECV(%)39.6±13.8 vs 22.8±5.0,均P < 0.05。
  • 实验组12例于6个月后复查平扫CMR:T2-STIR高信号仍可见但范围较急性期缩小,native-T1值(ms)1 271.0±26.9 vs 急性期1 434.5±165.3,T2值(ms)34.2±11.2 vs 急性期48.3±15.6,均P < 0.05。
  • ROC曲线分析native-T1值与T2值鉴别急性STEMI与CMI的AUC分别为0.71和0.80。
  • native-T1 cut-off值1 316.0 ms时特异性100%、敏感性53.3%;T2 cut-off值46.7 ms时特异性100%、敏感性73.8%。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为T2 mapping是无创诊断急性STEMI患者心肌改变的方法,并可用于评估患者的临床预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of T2 mapping in the assessment of myocardial changes and prognosis in patients with acute ST segment elevation myocardial infarction (STEMI).

METHODS: A retrospective study was conducted. A total of 30 patients with acute STEMI admitted to Tianjin First Central Hospital from January 2021 to March 2022 were enrolled as the experimental group. At the same time, 30 age- and sex-matched healthy volunteers and outpatients with non-specific chest pain with no abnormalities in cardiac magnetic resonance (CMR) examination were selected as the control group. CMR was performed within 2 weeks after the diagnosis of STEMI, as the initial reference. A plain CMR review was performed 6 months later (chronic myocardial infarction, CMI). Plain scanning includes film sequence (CINE), T2 weighted short tau inversion recovery (T2-STIR), native-T1 mapping, and T2 mapping. Enhanced scanning includes first-pass perfusion, late gadolinium enhancement (LGE), and post-contrast T1 mapping. Quantitative myocardial parameters were compared between the two groups, before and after STEMI myocardial infarction. The receiver operator characteristic curve (ROC curve) was used to evaluate the diagnostic efficacy of native-T1 before myocardial contrast enhancement and T2 values in differentiating STEMI and CMI after 6 months.

RESULTS: There were no statistically significant differences in age, gender, heart rate and body mass index (BMI) between the two groups, which were comparable. The native-T1 value, T2 value and extracellular volume (ECV) were significantly higher than those in the control group [native-T1 value (ms): 1 434.5±165.3 vs. 1 237.0±102.5, T2 value (ms): 48.3±15.6 vs. 21.8±13.1, ECV: (39.6±13.8)% vs. (22.8±5.0)%, all P < 0.05]. In the experimental group, 12 patients were re-examined by plain CMR scan 6 months later. After 6 months, the high signal intensity on T2-STIR was still visible, but the range was smaller than that in the acute phase, and the native-T1 and T2 values were significantly lower than those in the acute phase [native-T1 value (ms): 1 271.0±26.9 vs. 1 434.5±165.3, T2 value (ms): 34.2±11.2 vs. 48.3±15.6, both P < 0.05]. ROC curve analysis showed that the area under the ROC curve (AUC) of native-T1 and T2 values in differentiating acute STEMI from CMI was 0.71 and 0.80, respectively. When native-T1 cut-off value was 1 316.0 ms, the specificity was 100% and the sensitivity was 53.3%; when T2 cut-off value was 46.7 ms, the specificity was 100% and the sensitivity was 73.8%.

CONCLUSIONS: The T2 mapping is a non-invasive method for the diagnosis of myocardial changes in patients with acute STEMI myocardial infarction, and can be used to to evaluate the clinical prognosis of patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Cui Q, He Q, Ge X, et al. [Prognostic significance of T2 mapping in evaluating myocardium alterations in patients with ST segment elevation myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 38149394. doi:10.3760/cma.j.cn121430-20230914-00779

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。